Olopatadine Hydrochloride
It is a H1 receptor blocker and also inhibit action of production/release of chemical mediators (leukotrienes, thromboxane and platelet-aggregating factors).Allergic rhinitis, urticaria and itching accompanied by skin disease (eczema, dermatitis, pruritus cutaneous, psoriasis vulgaris, erythema exudativum multiforme.
Oral, 5mg twice daily.
Hypersensitivity
Patient with renal impairment. Paediatric: Safety not established in infants. Pregnancy: Safety not yet established. Lactation: Not recommended. Elderly: Use with caution.
Nausea or diarrhea, drowsiness or headache, weight gain, hot flushes, menstrual disorder.
| Brand Name | Manufactured by | 
|---|---|
| ACULO | ALDE MEDI IMPEX | 
| OLO-1 | NRI GLOBAL HEALTHCARE | 
| OLOADAY-7 | NRI GLOBAL HEALTHCARE | 
| OLODAY | NRI GLOBAL HEALTHCARE | 
| Oloitch-OD | JOHNLEE PHARMACEUTICALS PVT LTD |